Funding for this research was provided by:
National Institute of General Medical Sciences (T32GM007739)
Received: 9 February 2020
Accepted: 30 October 2020
First Online: 17 November 2020
Ethics approval and consent to participate
: The protocol and consent form have been reviewed and approved by the Memorial Sloan Kettering Cancer Center Institutional Review Board/Privacy Board. It has been determined that the protocol meets the U.S. Department of Health and Human Services regulatory criteria for research approval (45 CFR 46.111 and/or 21 CFR 56.111). The Memorial Sloan Kettering Cancer Center IRB Approval is number 18–196.Before protocol-specified procedures are carried out, consenting professionals, research staff associates and consenting physicians, will explain full details of the protocol and study procedures as well as the risks involved to participants prior to their inclusion in the study. Participants will also be informed that they are free to withdraw from the study at any time. All participants must sign an IRB/PB-approved consent form indicating their consent to participate. This consent form meets the requirements of the Code of Federal Regulations and the Institutional Review Board/Privacy Board of this Center. The consent form will include the following: OrderedList removedBefore any protocol-specific procedures can be carried out, the consenting professional will fully explain the aspects of patient privacy concerning research specific information. In addition to signing the IRB Informed Consent, all patients must agree to the Research Authorization component of the informed consent form. Each participant and consenting professional will sign the consent form. The participant must receive a copy of the signed informed consent form.
: Not Applicable.
: The authors declare that they have no competing interests.